154 related articles for article (PubMed ID: 37649596)
1. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer.
Wu YY; Hsu YL; Huang YC; Su YC; Wu KL; Chang CY; Ong CT; Lai JC; Shen TY; Lee TH; Hung JY; Tsai YM
Theranostics; 2023; 13(13):4412-4429. PubMed ID: 37649596
[No Abstract] [Full Text] [Related]
2. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals immune microenvironment of small cell lung cancer-associated malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Chen M; Wen F
Thorac Cancer; 2024 Jan; 15(1):98-103. PubMed ID: 38010064
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.
Whitfield HJ; Berthelet J; Mangiola S; Bell C; Anderson RL; Pal B; Yeo B; Papenfuss AT; Merino D; Davis MJ
Clin Transl Med; 2023 Sep; 13(9):e1356. PubMed ID: 37691350
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of IL-1β-producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Li X; Feng J
Thorac Cancer; 2022 Mar; 13(6):811-823. PubMed ID: 35137541
[TBL] [Abstract][Full Text] [Related]
7. Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma.
Liu D; Lu Y; Hu Z; Wu N; Nie X; Xia Y; Han Y; Li Q; Zhu G; Bai C
PLoS One; 2014; 9(2):e89946. PubMed ID: 24587142
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.
Chen SF; Lin YS; Jao SW; Chang YC; Liu CL; Lin YJ; Nieh S
PLoS One; 2013; 8(5):e54659. PubMed ID: 23658677
[TBL] [Abstract][Full Text] [Related]
10. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
Song Z; Wang W; Li M; Liu J; Zhang Y
Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis.
Yoshimura A; Yamada T; Tsuji T; Hamashima R; Shiotsu S; Yuba T; Takumi C; Uchino J; Hiraoka N; Takayama K
Thorac Cancer; 2019 Mar; 10(3):557-563. PubMed ID: 30672656
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
[TBL] [Abstract][Full Text] [Related]
13. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
[TBL] [Abstract][Full Text] [Related]
14. Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment.
Wang TF; Chu SC; Lee JJ; Yang GG; Huang WH; Chang ET; Low T; Wu YF; Kao RH; Lin CB
Asia Pac J Clin Oncol; 2017 Aug; 13(4):304-313. PubMed ID: 28124437
[TBL] [Abstract][Full Text] [Related]
15. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
Tang Y; Wang Z; Li Z; Kim J; Deng Y; Li Y; Heath JR; Wei W; Lu S; Shi Q
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2544-2549. PubMed ID: 28223509
[TBL] [Abstract][Full Text] [Related]
17. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Epidermal Growth Factor Receptor Gene Mutations Identified Using Pleural Effusion and Primary Tumor Tissue Samples in Non-Small Cell Lung Cancer.
Liu N; Sun RZ; Du J; Dong QZ; Fan CF; Li QC; Wang EH; Liu Y
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):e44-e51. PubMed ID: 28800007
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
[TBL] [Abstract][Full Text] [Related]
20. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
